表紙
市場調查報告書
商品編碼
1044416

適配體的全球市場:2022年∼2026年

Global Aptamers Market 2022-2026

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球適配體的市場規模在2022年∼2026年間,預測將成長到13億1,000萬美元,在預測期間中預計將以27.70%的年複合成長率增長。

市場成長的主要因素有隨著癌症患病率的增加,對新診斷的需求不斷增長,以及開發基於適配體的療法的臨床試驗數量不斷增加。。

本報告涵括適配體的全球市場的整體分析,提供市場規模與預測,趨勢,成長要素,課題,及約25供應商的分析。

目錄

摘要整理

市場形勢

  • 市場生態系統
  • 價值鏈分析

市場規模

  • 市場定義
  • 市場區隔分析
  • 2021年的市場規模
  • 市場預測:從2021年∼2026年的預測

波特的五力分析

  • 五力彙整
  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情況

市場區隔:各用途

  • 市場區隔
  • 各用途的比較
  • 治療方法的開發:市場規模與預測(2021年∼2026年)
  • 研究開發:市場規模與預測(2021年∼2026年)
  • 診斷:市場規模與預測(2021年∼2026年)
  • 其他:市場規模與預測(2021年∼2026年)
  • 各用途的市場機會

客戶形勢

各地區形勢

  • 各地區市場區隔
  • 各地區的比較
  • 北美:市場規模與預測(2021年∼2026年)
  • 歐洲:市場規模與預測(2021年∼2026年)
  • 亞洲:市場規模與預測(2021年∼2026年)
  • 其他地區:市場規模與預測(2021年∼2026年)
  • 主要國家
  • 各地區形勢的市場機會
  • 推動市場要素
  • 市場課題
  • 市場趨勢

業者情勢

  • 業者情勢
  • 創造性破壞狀況

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Aptagen LLC
  • Aptamer Group Ltd.
  • Aptamer Sciences Inc
  • APTATARGETS SL
  • Base Pair Biotechnologies Inc.
  • Kaneka Corp.
  • Maravai LifeSciences Holdings Inc.
  • NeoVentures Biotechnology Inc
  • SomaLogic Inc
  • Vivonics Inc

附錄

目錄
Product Code: IRTNTR71707

Technavio has been monitoring the aptamers market and it is poised to grow by $ 1.31 bn during 2022-2026, progressing at a CAGR of 27.70% during the forecast period. Our report on the aptamers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of cancer boosts demand for novel diagnostics and rising number of clinical trials to develop aptamer-based therapeutics. In addition, the increasing incidence of cancer boosts demand for novel diagnostics is anticipated to boost the growth of the market as well.

The aptamers market analysis includes the application segment and geographic landscape.

Technavio's aptamers market is segmented as below:

By Application

  • Therapeutics development
  • Research and development
  • Diagnostic
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the rising awareness of the advantages of aptamers over antibodiesas one of the prime reasons driving the aptamers market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on aptamers market covers the following areas:

  • Aptamers market sizing
  • Aptamers market forecast
  • Aptamers market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading aptamers market vendors that include Aptagen LLC, Aptamer Group Ltd., Aptamer Sciences Inc, APTATARGETS SL, Base Pair Biotechnologies Inc., Kaneka Corp., Maravai LifeSciences Holdings Inc., NeoVentures Biotechnology Inc, SomaLogic Inc, and Vivonics Inc. Also, the aptamers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market Overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2021
    • Market outlook: Forecast for 2021 - 2026
  • Five Forces Analysis
    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Application
    • Market segments
    • Comparison by Application
    • Therapeutics development - Market size and forecast 2021-2026
    • Research and development - Market size and forecast 2021-2026
    • Diagnostic - Market size and forecast 2021-2026
    • Others - Market size and forecast 2021-2026
    • Market opportunity by Application
  • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2021-2026
    • Europe - Market size and forecast 2021-2026
    • Asia - Market size and forecast 2021-2026
    • ROW - Market size and forecast 2021-2026
    • Key leading countries
    • Market opportunity By Geographical Landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Vendor landscape
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • Aptagen LLC
    • Aptamer Group Ltd.
    • Aptamer Sciences Inc
    • APTATARGETS SL
    • Base Pair Biotechnologies Inc.
    • Kaneka Corp.
    • Maravai LifeSciences Holdings Inc.
    • NeoVentures Biotechnology Inc
    • SomaLogic Inc
    • Vivonics Inc
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2021 - 2026 ($ million)
  • 13: Global market: Year-over-year growth 2021 - 2026 (%)
  • 14: Five forces analysis 2021 & 2026
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2021
  • 21: Application - Market share 2021-2026 (%)
  • 22: Comparison by Application
  • 23: Therapeutics development - Market size and forecast 2021-2026 ($ million)
  • 24: Therapeutics development - Year-over-year growth 2021-2026 (%)
  • 25: Research and development - Market size and forecast 2021-2026 ($ million)
  • 26: Research and development - Year-over-year growth 2021-2026 (%)
  • 27: Diagnostic - Market size and forecast 2021-2026 ($ million)
  • 28: Diagnostic - Year-over-year growth 2021-2026 (%)
  • 29: Others - Market size and forecast 2021-2026 ($ million)
  • 30: Others - Year-over-year growth 2021-2026 (%)
  • 31: Market opportunity by Application
  • 32: Customer landscape
  • 33: Market share By Geographical Landscape 2021-2026 (%)
  • 34: Geographic comparison
  • 35: North America - Market size and forecast 2021-2026 ($ million)
  • 36: North America - Year-over-year growth 2021-2026 (%)
  • 37: Europe - Market size and forecast 2021-2026 ($ million)
  • 38: Europe - Year-over-year growth 2021-2026 (%)
  • 39: Asia - Market size and forecast 2021-2026 ($ million)
  • 40: Asia - Year-over-year growth 2021-2026 (%)
  • 41: ROW - Market size and forecast 2021-2026 ($ million)
  • 42: ROW - Year-over-year growth 2021-2026 (%)
  • 43: Key leading countries
  • 44: Market opportunity By Geographical Landscape ($ million)
  • 45: Impact of drivers and challenges
  • 46: Vendor landscape
  • 47: Landscape disruption
  • 48: Industry risks
  • 49: Vendors covered
  • 50: Market positioning of vendors
  • 51: Aptagen LLC - Overview
  • 52: Aptagen LLC - Product and service
  • 53: Aptagen LLC - Key offerings
  • 54: Aptagen LLC - Key customers
  • 55: Aptagen LLC - Segment focus
  • 56: Aptamer Group Ltd. - Overview
  • 57: Aptamer Group Ltd. - Product and service
  • 58: Aptamer Group Ltd. - Key offerings
  • 59: Aptamer Group Ltd. - Key customers
  • 60: Aptamer Group Ltd. - Segment focus
  • 61: Aptamer Sciences Inc - Overview
  • 62: Aptamer Sciences Inc - Product and service
  • 63: Aptamer Sciences Inc - Key offerings
  • 64: Aptamer Sciences Inc - Key customers
  • 65: Aptamer Sciences Inc - Segment focus
  • 66: APTATARGETS SL - Overview
  • 67: APTATARGETS SL - Product and service
  • 68: APTATARGETS SL - Key offerings
  • 69: APTATARGETS SL - Key customers
  • 70: APTATARGETS SL - Segment focus
  • 71: Base Pair Biotechnologies Inc. - Overview
  • 72: Base Pair Biotechnologies Inc. - Product and service
  • 73: Base Pair Biotechnologies Inc. - Key offerings
  • 74: Base Pair Biotechnologies Inc. - Key customers
  • 75: Base Pair Biotechnologies Inc. - Segment focus
  • 76: Kaneka Corp. - Overview
  • 77: Kaneka Corp. - Business segments
  • 78: Kaneka Corp. - Key offerings
  • 79: Kaneka Corp. - Key customers
  • 80: Kaneka Corp. - Segment focus
  • 81: Maravai LifeSciences Holdings Inc. - Overview
  • 82: Maravai LifeSciences Holdings Inc. - Business segments
  • 83: Maravai LifeSciences Holdings Inc. - Key offerings
  • 84: Maravai LifeSciences Holdings Inc. - Key customers
  • 85: Maravai LifeSciences Holdings Inc. - Segment focus
  • 86: NeoVentures Biotechnology Inc - Overview
  • 87: NeoVentures Biotechnology Inc - Product and service
  • 88: NeoVentures Biotechnology Inc - Key offerings
  • 89: NeoVentures Biotechnology Inc - Key customers
  • 90: NeoVentures Biotechnology Inc - Segment focus
  • 91: SomaLogic Inc - Overview
  • 92: SomaLogic Inc - Product and service
  • 93: SomaLogic Inc - Key offerings
  • 94: SomaLogic Inc - Key customers
  • 95: SomaLogic Inc - Segment focus
  • 96: Vivonics Inc - Overview
  • 97: Vivonics Inc - Product and service
  • 98: Vivonics Inc - Key offerings
  • 99: Vivonics Inc - Key customers
  • 100: Vivonics Inc - Segment focus
  • 101: Currency conversion rates for US$
  • 102: Research Methodology
  • 103: Validation techniques employed for market sizing
  • 104: Information sources
  • 105: List of abbreviations